Coronado Biosciences develops novel immunotherapy biologic agents, with two principal pharmaceutical product candidates in clinical development: TSO, a biologic for the treatment of autoimmune diseases, such as Crohn’s disease, ulcerative colitis, and multiple sclerosis; and CNDO-109, a biologic that activates natural killer (NK) cells, for the treatment of acute myeloid leukemia (AML) and solid tumors. For more information visit the company’s Web site at www.coronadobiosciences.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: